Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer

For patients with stage III non-small-cell lung cancer with unresectable or inoperable tumors, definitive chemoradiotherapy is often utilized. Historically, local control and overall survival rates have been poor. In an effort to improve local control, new chemotherapeutic agents in combination with...

Descripción completa

Detalles Bibliográficos
Autores principales: Terakedis, Breanne, Sause, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355841/
https://www.ncbi.nlm.nih.gov/pubmed/22645713
http://dx.doi.org/10.3389/fonc.2011.00047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355841/
https://www.ncbi.nlm.nih.gov/pubmed/22645713
http://dx.doi.org/10.3389/fonc.2011.00047

Ejemplares similares